SN

Sunesis Pharmaceuticals

- NASDAQ:SNSS
Last Updated 2024-04-16
  • Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

  • Locations

    • South San Francisco CA

  • Total Funding (USD)

    43.5 million

  • Industries

    Real Estate, Mobile Apps, Video Games

  • Security

    Type: ORD
    CUSIP: 92765F108
    ISIN: US92765F1084
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo